[Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography]. 1970

T Motomiya

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D010991 Plethysmography Recording of change in the size of a part as modified by the circulation in it. Plethysmographies
D002219 Carbamates Derivatives of carbamic acid, H2NC( Carbamate,Aminoformic Acids,Carbamic Acids,Acids, Aminoformic,Acids, Carbamic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001162 Arteriosclerosis Obliterans Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION. Obliterans, Arteriosclerosis

Related Publications

T Motomiya
April 1969, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
T Motomiya
September 1967, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
T Motomiya
March 1977, International journal of clinical pharmacology and biopharmacy,
T Motomiya
April 2016, Nihon rinsho. Japanese journal of clinical medicine,
T Motomiya
June 1964, Journal of the Oslo city hospitals,
T Motomiya
November 1972, La Revue du praticien,
Copied contents to your clipboard!